263 related articles for article (PubMed ID: 26819314)
1. Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor.
Murata T; Noda C; Narita Y; Watanabe T; Yoshida M; Ashio K; Sato Y; Goshima F; Kanda T; Yoshiyama H; Tsurumi T; Kimura H
J Virol; 2016 Apr; 90(8):3873-3889. PubMed ID: 26819314
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
3. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
Sjöblom A; Jansson A; Yang W; Laín S; Nilsson T; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375
[TBL] [Abstract][Full Text] [Related]
4. Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.
Wang Q; Lingel A; Geiser V; Kwapnoski Z; Zhang L
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794023
[TBL] [Abstract][Full Text] [Related]
5. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
Price AM; Messinger JE; Luftig MA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
[TBL] [Abstract][Full Text] [Related]
6. Role of a consensus AP-2 regulatory sequence within the Epstein-Barr virus LMP1 promoter in EBNA2 mediated transactivation.
Jansson A; Johansson P; Yang W; Palmqvist L; Sjöblom-Hallén A; Rymo L
Virus Genes; 2007 Oct; 35(2):203-14. PubMed ID: 17546492
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1.
Noda C; Murata T; Kanda T; Yoshiyama H; Sugimoto A; Kawashima D; Saito S; Isomura H; Tsurumi T
J Biol Chem; 2011 Dec; 286(49):42524-42533. PubMed ID: 22013073
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.
Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M
Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871
[TBL] [Abstract][Full Text] [Related]
9. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
10. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1.
Yoshizaki T; Sato H; Furukawa M; Pagano JS
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3621-6. PubMed ID: 9520415
[TBL] [Abstract][Full Text] [Related]
11. Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells.
Cotter M; Callahan J; Aster J; Robertson E
J Virol; 2000 Feb; 74(3):1486-94. PubMed ID: 10627560
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.
Wakisaka N; Kondo S; Yoshizaki T; Murono S; Furukawa M; Pagano JS
Mol Cell Biol; 2004 Jun; 24(12):5223-34. PubMed ID: 15169887
[TBL] [Abstract][Full Text] [Related]
13. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
Thornburg NJ; Raab-Traub N
J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
[TBL] [Abstract][Full Text] [Related]
14. Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
Chen H; Lee JM; Zong Y; Borowitz M; Ng MH; Ambinder RF; Hayward SD
J Virol; 2001 Mar; 75(6):2929-37. PubMed ID: 11222718
[TBL] [Abstract][Full Text] [Related]
15. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R
Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478
[TBL] [Abstract][Full Text] [Related]
16. The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB.
Zuo L; Yu H; Liu L; Tang Y; Wu H; Yang J; Zhu M; Du S; Zhao L; Cao L; Li G; Lu J
Oncotarget; 2015 Dec; 6(38):41033-44. PubMed ID: 26517512
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers.
Fischer N; Kopper B; Graf N; Schlehofer JR; Grässer FA; Mueller-Lantzsch N
Virus Res; 1999 Mar; 60(1):41-54. PubMed ID: 10225273
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
19. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
[TBL] [Abstract][Full Text] [Related]
20. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
Zhao B; Sample CE
J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
